Kailos Genetics
Consumers access to affordable physician-ordered genetic tests.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor | €0.0 | round |
| N/A | €0.0 | round | |
| investor | €0.0 | round | |
* | N/A | Acquisition | |
| Total Funding | 000k | ||
Related Content
Kailos Genetics specializes in providing personalized genetic testing services that empower individuals to make informed health decisions. Founded in 2010, the company leverages insights from the Human Genome Project to offer consumers an easy and affordable way to understand their genetic makeup. Kailos serves both individual consumers and medical professionals, offering a range of tests that identify DNA changes related to health risks, such as certain forms of cancer. The company's business model revolves around direct-to-consumer sales and partnerships with healthcare providers. Revenue is generated through the sale of genetic testing kits and associated services. Kailos differentiates itself with a simple testing process that requires no needles or waiting rooms, and provides easy-to-read health reports. The company operates in the personalized healthcare market, focusing on genetic testing and health information services.
Keywords: genetic testing, personalized healthcare, DNA changes, cancer risk, Human Genome Project, direct-to-consumer, health reports, medical professionals, affordable testing, health decisions.